Ecancermedicalscience

Ecancermedicalscience · ISSN (print) 1754-6605 · 21 papers in corpus
case-report 2024
doi:10.3332/ecancer.2024.1701 ·PMID:39021548

BACKGROUND: Multilocus inherited neoplasia allelic syndrome (MINAS) is a recently coined term that describes the coexistence of two or more pathogenic variants (PVs) in cancer susceptibility genes (CSGs) in a single individual. CASE PRESEN…

diagnostic-accuracy 2023
doi:10.3332/ecancer.2023.1568 ·PMID:37533954

This prospective cross-sectional study compared the diagnostic accuracy of human epididymal protein 4 (HE4) with cancer antigen 125 (CA 125) and validates the risk of malignancy algorithm (ROMA) in differentiating benign from malignant ovar…

observational 2023
doi:10.3332/ecancer.2023.1591 ·PMID:37799950

BACKGROUND: Malignant transformation in endometriosis was first described by Sampson in 1925. There is now sufficient evidence of its association specifically with endometrioid (EOC) and clear cell ovarian cancer (CCOC). Whether endometrios…

2023
doi:10.3332/ecancer.2023.1495 ·PMID:36816788

IntroductionIn Ghana, the Papanicolaou (PAP) smear remains central to cervical cancer screening although human papilloma virus testing is recommended. The success of the PAP smear however depends on stringent quality processes. Unfortunatel…

review 2022
doi:10.3332/ecancer.2022.1416 ·PMID:36072240

Millions of women have given preference to the use of combined oral contraceptives (COCs) since its introduction in the 1960s. Both oestrogens and progestogens can regulate proliferation and it is plausible these effects may contribute to c…

review 2020
doi:10.3332/ecancer.2020.1031 ·PMID:32419843

Borderline ovarian tumours (BOTs) are ovarian neoplasms characterised by epithelial proliferation, variable nuclear atypia and no evidence of destructive stromal invasion. BOTs account for approximately 15% of all epithelial ovarian cancers…

review 2020
doi:10.3332/ecancer.2020.1071 ·PMID:32728387

Breast cancer (BC) is the most frequent cancer among women in the world and it remains a leading cause of cancer death in women globally. Among BCs, triple negative breast cancer (TNBC) is the most aggressive, and for its histochemical and …

review 2020
doi:10.3332/ecancer.2020.1034 ·PMID:32419846

Uterine fibroids (UFs) are the most common benign tumours of the female reproductive system and the most frequent reason for hysterectomy worldwide. UFs are reported in 20%-70% of women of reproductive age depending on a study group. Althou…

case-report 2019
doi:10.3332/ecancer.2019.979 ·PMID:31921350

We realized a narrative review of the current literature starting from the case of a patient with raised CA15-3 during an uncomplicated pregnancy after breast cancer. The aim of our paper was to assess specificity, physiological changes and…

review 2018
doi:10.3332/ecancer.2018.803 ·PMID:29456620

Endometriosis is a fascinating disease that we strive to better understand. Molecular techniques are shedding new light on many important aspects of this disease: from pathogenesis to the recognition of distinct disease variants like deep i…

review 2018
doi:10.3332/ecancer.2018.794 ·PMID:29434660

High-intensity focused ultrasound (HIFU) is a minimally invasive technique that has been used for the treatment of both benign and malignant tumours. With HIFU, an ultrasound (US) beam propagates through soft tissue as a high-frequency pres…

2018
doi:10.3332/ecancer.2018.886 ·PMID:30679953

Repurposing is a drug development strategy that seeks to use existing medications for new indications. In oncology, there is an increased level of activity looking at the use of non-cancer drugs as possible cancer treatments. The Repurposin…

other 2017
doi:10.3332/ecancer.2017.ed62 ·PMID:28275393

Gynaecological cancer is a very stressful experience for women and treatments can compromise fertility and reproductive capacity. Fertility preservation techniques in women with gynaecological cancer can play an important role in improving …

case-report 2016
doi:10.3332/ecancer.2016.678 ·PMID:27899951

Multicystic mesothelioma (MM) is a relatively rare tumour arising in the pelvic peritoneum of the tuboovarian region of young woman. Exceptionally, MM occurs on the serosal surfaces of various organs including kidney, bladder, lymph nodes, …

observational 2016
doi:10.3332/ecancer.2016.628 ·PMID:27110284

BACKGROUND: The incidence and mortality estimates of ovarian cancer based on human development are essential for planning by policy makers. This study is aimed at investigating the standardised incidence rates (SIR) and standardised mortali…

review 2015
doi:10.3332/ecancer.2015.584 ·PMID:26557882

Epithelial ovarian cancer is often considered a single pathological entity, but increasing evidence suggests that it is rather a group of different neoplasms, each with unique pathological characteristics, molecular features, and clinical b…

review 2014
doi:10.3332/ecancer.2014.403 ·PMID:24605135

Borderline ovarian tumours differ from epithelial ovarian cancer by their low incidence, frequent association with infertility, low association with mutations in BCRA genes, different percentages of the most common histological types, early…

review 2014
doi:10.3332/ecancer.2014.465 ·PMID:25371706

Ovarian cancer is a disease laden with paradigms, and it is a serious health problem. It is important to know its natural history, as it is multifactorial in origin, and also to understand its behaviour given its risk factors which can lead…

case-report 2013
doi:10.3332/ecancer.2013.335 ·PMID:23888184

Gonadotropin-releasing hormone (GnRH) agonists are used for gonadal suppression in the treatment of breast and prostate cancers. In older men, their use has occasionally been associated with cardiovascular side effects such as supraventricu…

case-report 2013
doi:10.3332/ecancer.2013.295 ·PMID:23589725

Primary peritoneal carcinomas are rare, highly aggressive malignant neoplasms containing both sarcomatous and carcinomatous elements. Surgical debulking is the mainstay of treatment for primary peritoneal carcinomas. Systemic chemotherapy i…

case-report 2012
doi:10.3332/ecancer.2012.284 ·PMID:23304240

OBJECTIVE: Ovarian adenosarcoma is a very rare tumour for which treatment options vary. We will consider the option of optimal cytoreductive surgery followed by adjuvant chemotherapy consisting of ifosamide (mesna) and adriamycin to prevent…